Targeted mupirocin-based decolonization for Staphylococcus aureus carriers and the subsequent risk of mupirocin resistance in haemodialysis patients – a longitudinal study over 20 years

Autor: Hassoun-Kheir, N. ^{a, ∗}, Buetti, N. ^{a, b}, Olivier, V. ^c, Perez, M. ^a, Frossard, J. ^a, Renzi, G. ^d, Schrenzel, J. ^{d, e}, Saudan, P. ^{c, †}, Harbarth, S. ^{a, †}

Publikováno v: In Journal of Hospital Infection May 2023 135:55-58

Effect of islet alone or islets after kidney transplantation on quality of life in type 1 diabetes: A systematic review.

Autor: Gariani K; Division of Endocrinology, Diabetes, Nutrition and Patient Therapeutic Education, Geneva University Hospitals, Geneva, Switzerland. Electronic address: karim.gariani@hcuge.ch., Peloso A; Division of Transplantation, Department of Surgery, Geneva University Hospitals, Geneva, Switzerland., Galani V; Service of Liaison Psychiatry and Crisis Intervention, Department of Psychiatry, Geneva University Hospitals, Geneva, Switzerland., Haidar F; Division of Transplantation, Department of Surgery, Geneva University Hospitals, Geneva, Switzerland; Division of Nephrology and Hypertension, Department of Medicine, Geneva University Hospitals, Geneva, Switzerland., Wassmer CH; Division of Transplantation, Department of Surgery, Geneva University Hospitals, Geneva, Switzerland., Kumar R; Division of Transplantation, Department of Surgery, Geneva University Hospitals, Geneva, Switzerland., Lacin EH; Division of Transplantation, Department of Surgery, Geneva University Hospitals, Geneva, Switzerland., Olivier V; Division of Nephrology and Hypertension, Department of Medicine, Geneva University Hospitals, Geneva, Switzerland; Transplantation Immunology Unit and National Reference Laboratory for Histocompatibility, Department of Diagnostic, Geneva University Hospitals, Geneva, Switzerland., Prada P; Service of Liaison Psychiatry and Crisis Intervention, Department of Psychiatry, Geneva University Hospitals, Geneva, Switzerland., Compagnon P; Division of Transplantation, Department of Surgery, Geneva University Hospitals, Geneva, Switzerland., Berishvili E; Division of Transplantation, Department of Surgery, Geneva University Hospitals, Geneva, Switzerland; Cell Isolation and Transplantation Centre, Department of Surgery, Geneva University Hospitals, Geneva, Switzerland; Department of Surgery, Laboratory of Tissue Engineering and Organ Regeneration, University of Geneva, Geneva, Switzerland; Ilia State University School of Medicine, Tbilisi, Georgia., Berney T; Cell Isolation and Transplantation Centre, Department of Surgery, Geneva University Hospitals, Geneva, Switzerland; Ilia State University School of Medicine, Tbilisi, Georgia; Division of Nephrology, Immunology and Transplantation, Hôpital Edouard Herriot, Hospices Civils de Lyon, Lyon, France.

Publikováno v: Transplantation reviews (Orlando, Fla.) [Transplant Rev (Orlando)] 2024 Dec; Vol. 38 (4), pp. 100870. Date of Electronic Publication: 2024 Jun 21.

Clisson, Olivier V de (1336-1407)

Autor: Michael C. Jones

Publikováno v: The Encyclopedia of War

Clisson was the last direct male descendant of an important marcher family of Breton lords dating back to the eleventh century. As both soldier and councillor, he shaped events not only in his native Brittany, but also nationally under Charles V and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b96f0dc23c61f43756c33c31765806a7
https://doi.org/10.1002/9781444338232.wbeow125

Isatuximab, lenalidomide, dexamethasone and bortezomib in transplant-ineligible multiple myeloma: the randomized phase 3 BENEFIT trial.

Autor: Leleu X; Hematology, CIC 1082, U1313, CHU, University, Poitiers, France. xavier.leleu@chu-poitiers.fr., Hulin C; CHU, Bordeaux, France., Lambert J; SBIM, Saint-Louis Hospital, Paris, France., Bobin A; Hematology, CIC 1082, U1313, CHU, University, Poitiers, France., Perrot A; University Hospital, iUCT Oncopole, Toulouse, France., Karlin L; Hôpital Lyon Sud, Pierre-Benite, France., Roussel M; Hematology, CHU, Limoges, France., Montes L; Hematology, CHU, Amiens, France., Cherel B; CH Bretagne Atlantique, Vannes, France., Chalopin T; Hematology, CHU, Tours, France., Slama B; Hospital center, Avignon, France., Chretien ML; Hematology, University Hospital, Inserm U1231, University of Burgundy Franche-Comté, Dijon, France., Laribi K; Hematology, CH, Le Mans, France., Dingremont C; Internal Medicine, Tarbes-Lourdes Hospital, Tarbes, France., Roul C; CH La Rochelle, La Rochelle, France., Mariette C; Hematology, CHU, Grenoble, France., Rigaudeau S; Hématologie - Le Chesnay, CH Versaille, Paris, France., Calmettes C; CH, Périgueux, France., Dib M; University Hospital, Angers, France., Tiab M; Hematology, CH Departemental de La Roche-sur-Yon, La Roche-sur-Yon, France., Vincent L; CHU, Montpellier, France., Delaunay J; Hôpital privé du confluent 2, Nantes, France., Santagostino A; Hematology, CH, Troyes, France., Macro M; Hematology, IHBN - CHU, Caen, France., Bourgeois E; GHICL, Lille, France., Orsini-Piocelle F; Hématologie, CH, Annecy Genevois, France., Gay J; Hematology, CH de la côte basque, Bayonne, France., Bareau B; Hematology, Les Hôpitaux Privés Rennais Cesson Sévigné - Vivalto Santé, Cesson Sévigné, France., Bigot N; SBIM, Saint-Louis Hospital, Paris, France., Vergez F; Unit for Genomics in Myeloma, iUCT Oncopole, Toulouse, France., Lebreton P; Hematology, CH, Le Havre, France., Tabrizi R; Hematology, CHI de Mont De Marsan, Mont-de-Marsan, France., Waultier-Rascalou A; Hematology, CHU, Nîmes, France., Frenzel L; Hematology, Necker Hospital, Paris, France., Le Calloch R; Hematology, CH de Cornouaille, Quimper Concarneau, Concarneau, France., Chalayer E; Hematology, CHU, Saint-Etienne, France., Braun T; Hematology, Avicenne hospital APHP, Bobigny, France., Lachenal F; CH Pierre Oudot, Bourgoin-Jallieu, France., Corm S; Medipole de Savoie, Challes les Eaux, France., Kennel C; CH William Morey, Chalon sur Saône, France., Belkhir R; Rheumatology, Hopital Bicetre, AP-HP, Universite Paris Saclay, Paris, France., Bladé JS; Onco-Hematology Department, HIA Sainte Anne, Toulon, France., Joly B; CH Sud Francilien, Corbeil Essonnes, France., Richez-Olivier V; CHU de Nice, Nice, France., Gardeney H; Hematology, CIC 1082, U1313, CHU, University, Poitiers, France., Demarquette H; Hematology, CH, Dunkerque, France., Robu-Cretu D; Hematology, CH, Lens, France., Garderet L; Hopital Pitié Salpetriere, hématologie APHP, Paris, France., Newinger-Porte M; Hôpital Emile Muller, Mulhouse, France., Kasmi A; DRC, CHU, Poitiers, France., Royer B; Hôpital Saint-Louis, Paris, France., Decaux O; Hematology, UMR U1236, University Hospital, Rennes, France., Arnulf B; Hôpital Saint-Louis, Paris, France., Belhadj K; C.H.U. Henri Mondor, Créteil, France., Touzeau C; Hématologie, CHU Hotel Dieu Université, Nantes, France., Mohty M; Hematology, Sorbonne University, Saint-Antoine Hôpital (AP-HP), UMRs 938, Paris, France., Manier S; Hematology, University Hospital Inserm U-S1277 and CNRS UMR9020, Lille, France., Moreau P; Hématologie, CHU Hotel Dieu Université, Nantes, France., Avet-Loiseau H; Unit for Genomics in Myeloma, iUCT Oncopole, Toulouse, France., Corre J; Unit for Genomics in Myeloma, iUCT Oncopole, Toulouse, France., Facon T; Hematology, University Hospital Inserm U-S1277 and CNRS UMR9020, Lille, France.

Publikováno v: Nature medicine [Nat Med] 2024 Aug; Vol. 30 (8), pp. 2235-2241. Date of Electronic Publication: 2024 Jun 03.

An Introduction to High-Frequency Finance: Michael M. Dacorogna, Ramazan Gençay, Ulrich Müller, Richard B. Olsen, and Olivier V. Pictet. San Diego, CA: Academic Press, 2001. 383 pp., $79.95, ISBN: 0-12-279671-3

Autor: Terzi, Andrea ^*

Publikováno v: In International Review of Economics and Finance 2003 12(4):525-529